Bone Grafts And Substitutes Market 2023 Global Key Players, Industry Analysis, Potential Growth, Latest Trends 2032

As per The Business Research Company's Bone Grafts And Substitutes Opportunities And Strategies Market Report 2023, The bone grafts and substitutes market reached a value of nearly $2,927.3 million in 2022, having grown at a compound annual growth rate (CAGR) of 3.7% since 2017. The market is expected to grow from 2,927.31 million in 2022 to $3,768.05 million in 2027 at a rate 5.2%. The market is then expected to grow at a CAGR of 5.8%from 2027 and reach $4,983.52 million in 2032.

During the forecast period, the rising number of amputations due to diabetes will drive the growth of the bone grafts and substitutes market. Amputation is a major complication of diabetes resulting in the surgical removal of a toe, a foot or part of a leg. Amputation is mainly caused by high blood sugar levels. The rising number of diabetes-related amputations will create a significant demand for bone grafts and substitutes, as they aid in the replacement of a toe, a foot or part of a leg, supporting the functions of the body parts being removed. For instance, according to an estimation by the Center for Disease Control and Prevention (CDC), 1 in 5 Americans (US) will have diabetes by 2025. This statistic indicates that amputations will increase due to the high prevalence of diabetes. Therefore, this will drive the growth of the bone grafts and substitutes market.

View Complete Report @
https://www.thebusinessresearchcompany.com/report/bone-grafts-and-substitutes-market

Major companies operating in the bone grafts and substitutes market are focused on developing new products to strengthen their position in the market. For example, in March 2022, Molecular Matrix Inc (MMI), a US-based regenerative medicine polymer technology company, launched an Osteo-P Synthetic Bone Graft Substitute (BGS) for use in the musculoskeletal system. The hyper-crosslinked carbohydrate polymer (HCCP) technology platform from MMI is used to create Osteo-P BGS and has been designed to optimize the microenvironment for bone repair and regeneration. Further, in February 2022, Orthofix Medical Inc (OFIX), a US-based medical device company with a spine and orthopedics focus, launched Opus BA, a synthetic bioactive bone graft solution for cervical and lumbar spine fusion procedures. Opus BA can be used to fill skeletal system gaps or holes that are not essential to the stability of the bony structure. During the healing process, Opus BA functions as a scaffold, allowing bone to form over the surface before being reabsorbed and replaced with normal bone.

The top opportunities in the bone grafts and substitutes market segmented by material will arise in the allografts segment, which will gain $467.5 million of global annual sales by 2027. The top opportunities in segment by end-user will arise in the hospitals and clinics segment, which will gain $610.8 million of global annual sales by 2027. The top opportunities in segment by application will arise in the spinal fusion segment, which will gain $466.2 million of global annual sales by 2027. The bone grafts and substitutes market size will gain the most in the USA at $305.7 million.

Bone Grafts And Substitutes Market Segmentation:
The Bone Grafts And Substitutes market is segmented By Material, By Application, By End-User

By Material -
a) Allograft
b) Synthetic
c) Xenograft

By Application
a) Spinal Fusion
b) Trauma
c) Craniomaxillofacial
d) Joint Reconstruction
e) Dental Bone Grafting
f) Other Applications
By End-User -
a) Hospitals And Clinics
b) Surgical Centers
c) Other End-Users

Major players in the Bone Grafts And Substitutes market include Medtronic plc, Stryker Corporation, Smith & Nephew, Johnson & Johnson, Zimmer Biomet

The regions covered in the global Bone Grafts And Substitutes market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=8644&type=smp

The latest report from The Business Research Company, 'Global Bone Grafts And Substitutes Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Bone Grafts And Substitutes Market Report Table Of Content
1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
……
19. Company Profiles
20. Key Mergers and Acquisitions
21. Opportunities And Strategies
22. Bone Grafts And Substitutes Market, Conclusions And Recommendations
23. Appendix

PURCHASE the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8644

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.